Cancer Dictionary

Apoptosis inhibitors are substances that prevent or delay the process of apoptosis, which is the programmed cell death essential for maintaining healthy cell turnover and development in the body. These inhibitors can be used in medical treatments to protect cells from premature death, especially in diseases where cell survival is compromised.

Small molecule inhibitors are a type of medication designed to block specific enzymes or proteins in cells that contribute to disease processes, such as cancer. These drugs are typically small enough to enter cells easily and interfere with the function of target molecules, helping to slow or stop the progression of diseases.

Tumor-infiltrating lymphocytes (TILs) are immune cells that have moved from the bloodstream into a tumor. They are part of the body's natural defense system and can recognize and attack cancer cells, which can help in slowing down or stopping tumor growth.

Topoisomerase inhibitors are medications that interfere with the action of topoisomerase enzymes, which help manage the structure of DNA during cell division. These inhibitors are primarily used in cancer treatment to prevent cancer cells from proliferating.

Adjuvant endocrine therapy is a treatment used to reduce the risk of cancer coming back after primary treatments like surgery. It involves using hormone-blocking drugs to prevent cancer cells from growing, particularly in hormone-sensitive cancers like breast cancer.

Antibody-dependent cellular cytotoxicity (ADCC) is a process where immune cells target and destroy cells that are marked by antibodies. This mechanism is crucial for eliminating infected or cancerous cells in the body.

B-cell maturation antigen (BCMA) is a protein found on the surface of B cells, which are a type of white blood cell involved in the immune response. BCMA plays a crucial role in the growth, survival, and differentiation of these cells.

Breast conservation surgery, also known as lumpectomy, is a surgical procedure aimed at removing a tumor or abnormal tissue from the breast while preserving as much of the breast as possible. It is often used in the treatment of early-stage breast cancer and is typically followed by radiation therapy to minimize the risk of cancer recurrence.

Combination therapy refers to the use of more than one medication or treatment approach to treat a disease or condition. This method is often used to enhance the effectiveness of treatment, reduce side effects, and prevent drug resistance.

Electrochemotherapy is a medical treatment that combines chemotherapy and electrical pulses to enhance the effectiveness of anti-cancer drugs, primarily used for treating skin and subcutaneous tumors.

Intrathecal chemotherapy is a type of cancer treatment where chemotherapy drugs are injected directly into the cerebrospinal fluid surrounding the brain and spinal cord. This method is used to target cancer cells in the central nervous system.

Palliative chemotherapy is a type of cancer treatment aimed at relieving symptoms and improving quality of life for patients with advanced cancer. It is not intended to cure the cancer but to manage pain and other symptoms.

Radiation fibrosis syndrome is a condition that occurs when healthy tissue becomes scarred and stiff after exposure to radiation therapy, commonly used in cancer treatment. This can lead to a range of symptoms depending on the area affected, including pain, restricted movement, and functional impairments.

Radiation necrosis is a condition where healthy tissue is damaged and dies as a result of exposure to radiation therapy, typically used in cancer treatment. This can lead to symptoms such as swelling, neurological deficits, and other complications depending on the area affected.

Survivorship care refers to the comprehensive healthcare and support provided to individuals who have completed initial cancer treatment. It focuses on monitoring for recurrence, managing long-term side effects, and addressing psychosocial needs to help survivors lead healthy lives.

Systemic therapy refers to the use of medication or treatment that affects the entire body rather than a specific area or part. It is commonly used to treat diseases that have spread throughout the body, such as cancer, by circulating through the bloodstream to reach cells in various locations.

VEGF inhibitors are medications that block the action of vascular endothelial growth factor (VEGF), a protein that promotes blood vessel formation. These inhibitors are used to treat various conditions, primarily certain types of cancer and eye diseases, by restricting the growth of blood vessels that supply nutrients to tumors or affect vision.

Vaccine therapy is a treatment approach that uses vaccines to stimulate the body's immune system to fight diseases, particularly infections and certain types of cancer.

Valrubicin is a chemotherapy drug used primarily to treat bladder cancer that has not responded to other treatments. It works by interfering with the growth of cancer cells, slowing or stopping their spread.

A haploidentical donor is a family member whose tissue type matches exactly half of the recipient's human leukocyte antigen (HLA) markers, used often in bone marrow transplants when a fully matched donor is not available.

An allogeneic bone marrow transplant is a medical procedure where a patient receives healthy blood-forming stem cells from a genetically similar, but not identical, donor to replace their damaged or diseased bone marrow.

An allogeneic stem cell transplant is a medical procedure where a patient receives blood-forming stem cells from a genetically similar, but not identical, donor. This treatment is often used for conditions affecting the bone marrow or blood, such as leukemia and lymphoma.

Hedgehog pathway inhibitors are a class of drugs that block the Hedgehog signaling pathway, which is involved in cell growth and development. These inhibitors are primarily used in treating certain types of cancer where this pathway is abnormally activated.